MicroRNA-221-3p Targets THBS1 to Promote Wound Healing in Diabetes

References

• Armstrong DG, Boulton A, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375.
   PubMed Web of Science ®Google Scholar
• Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–1724. doi:10.1016/S0140-6736(05)67698-2
   PubMed Web of Science ®Google Scholar
• Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366(9498):1736–1743. doi:10.1016/S0140-6736(05)67700-8
   PubMed Web of Science ®Google Scholar
• van Netten JJ, Price PE, Lavery LA, et al. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32(1):84–98. doi:10.1002/dmrr.2701
   PubMedGoogle Scholar
• Kale A, Rogers NM, Ghimire K. Thrombospondin-1 CD47 signalling: from mechanisms to medicine. Int J Mol Sci. 2021;22: doi:10.3390/ijms22084062.
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Imajoh-Ohmi S, Shibuya M. Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle. Cancer Sci. 2007;98(9):1491–1497. doi:10.1111/j.1349-7006.2007.00534.x
   PubMed Web of Science ®Google Scholar
• Morandi V, Petrik J, Lawler J. Endothelial cell behavior is determined by receptor clustering induced by thrombospondin-1. Front Cell Dev Biol. 2021;9:664696. doi:10.3389/fcell.2021.664696
   PubMed Web of Science ®Google Scholar
• Bayraktar M, Dündar S, Kirazli S, Teletar F. Platelet factor 4, beta-thromboglobulin and thrombospondin levels in type I diabetes mellitus patients. J Int Med Res. 1994;22(2):90–94. doi:10.1177/030006059402200204
   PubMed Web of Science ®Google Scholar
• Hong Z, Chen H, Hong H, Lin L, Wang Z. TSP-1 expression changes in diabetic rats with spinal cord injury. Neurol Res. 2009;31(8):878–882. doi:10.1179/174313209X403887
   PubMed Web of Science ®Google Scholar
• Ross K. MiR equal than others: microRNA enhancement for cutaneous wound healing. J Cell Physiol. 2021;236(12):8050–8059. doi:10.1002/jcp.30485
   PubMed Web of Science ®Google Scholar
• Li D, Wang A, Liu X, et al. MicroRNA-132 enhances transition from inflammation to proliferation during wound healing. J Clin Invest. 2015;125(8):3008–3026. doi:10.1172/JCI79052
   PubMed Web of Science ®Google Scholar
• Li M, Ke QF, Tao SC, Guo SC, Rui BY, Guo YP. Fabrication of hydroxyapatite/chitosan composite hydrogels loaded with exosomes derived from miR-126-3p overexpressed synovial mesenchymal stem cells for diabetic chronic wound healing. J Mater Chem B. 2016;4(42):6830–6841. doi:10.1039/C6TB01560C
   PubMed Web of Science ®Google Scholar
• Wang SY, Kim H, Kwak G, et al. Development of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds. Theranostics. 2020;10(7):3240–3253. doi:10.7150/thno.39870
   PubMed Web of Science ®Google Scholar
• Xu J, Bai S, Cao Y, et al. miRNA-221-3p in endothelial progenitor cell-derived exosomes accelerates skin wound healing in diabetic mice. Diabetes Metab Syndr Obes. 2020;13:1259–1270. doi:10.2147/DMSO.S243549
   PubMed Web of Science ®Google Scholar
• Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis †. Ann Med. 2017;49(2):106–116. doi:10.1080/07853890.2016.1231932
   PubMed Web of Science ®Google Scholar
• Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51(5):747–755. doi:10.1007/s00125-008-0940-0
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314–321. doi:10.1038/nature07039
   PubMed Web of Science ®Google Scholar
• Eckert RL, Efimova T, Dashti SR, et al. Keratinocyte survival, differentiation, and death: many roads lead to mitogen-activated protein kinase. J Investig Dermatol Symp Proc. 2002;7(1):36–40. doi:10.1046/j.1523-1747.2002.19634.x
   PubMedGoogle Scholar
• Baltzis D, Eleftheriadou I, Veves A. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther. 2014;31(8):817–836. doi:10.1007/s12325-014-0140-x
   PubMed Web of Science ®Google Scholar
• Li D, Peng H, Qu L, et al. miR-19a/b and miR-20a promote wound healing by regulating the inflammatory response of keratinocytes. J Invest Dermatol. 2021;141(3):659–671. doi:10.1016/j.jid.2020.06.037
   PubMed Web of Science ®Google Scholar
• Hu SC, Lan CE. High-glucose environment disturbs the physiologic functions of keratinocytes: focusing on diabetic wound healing. J Dermatol Sci. 2016;84(2):121–127. doi:10.1016/j.jdermsci.2016.07.008
   PubMed Web of Science ®Google Scholar
• Streit M, Velasco P, Brown LF, et al. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol. 1999;155(2):441–452. doi:10.1016/S0002-9440(10)65140-1
   PubMed Web of Science ®Google Scholar
• Liu Z, Morgan S, Ren J, et al. Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm. Circ Res. 2015;117(2):129–141. doi:10.1161/CIRCRESAHA.117.305262
   PubMed Web of Science ®Google Scholar
• Streit M, Velasco P, Riccardi L, et al. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J. 2000;19(13):3272–3282. doi:10.1093/emboj/19.13.3272
   PubMed Web of Science ®Google Scholar
• Lan CC, Huang SM, Wu CS, Wu CH, Chen GS. High-glucose environment increased thrombospondin-1 expression in keratinocytes via DNA hypomethylation. Transl Res. 2016;169:91–101.e1-3. doi:10.1016/j.trsl.2015.11.002
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care. 2020;43: S135-s151. doi:10.2337/dc20-S011.
   Web of Science ®Google Scholar
• Petkovic M, Sørensen AE, Leal EC, Carvalho E, Dalgaard LT. Mechanistic actions of microRNAs in diabetic wound healing. Cells. 2020;9:2228. doi:10.3390/cells9102228
   PubMed Web of Science ®Google Scholar
• Pan X, Hong X, Lai J, et al. Exosomal MicroRNA-221-3p confers adriamycin resistance in breast cancer cells by targeting PIK3R1. Front Oncol. 2020;10:441. doi:10.3389/fonc.2020.00441
   PubMed Web of Science ®Google Scholar
• Wei WF, Zhou CF, Wu XG, et al. MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2. Cell Death Dis. 2017;8(12):3220. doi:10.1038/s41419-017-0077-5
   PubMed Web of Science ®Google Scholar
• Zhao J, Cui L, Sun J, et al. Notoginsenoside R1 alleviates oxidized low-density lipoprotein-induced apoptosis, inflammatory response, and oxidative stress in HUVECS through modulation of XIST/miR-221-3p/TRAF6 axis. Cell Signal. 2020;76:109781. doi:10.1016/j.cellsig.2020.109781
   PubMed Web of Science ®Google Scholar
• Jiménez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med. 2000;6(1):41–48. doi:10.1038/71517
   PubMed Web of Science ®Google Scholar